Alkem

{{ Form::open(['url' => '#', 'name' => 'validateForm', 'id' => 'validateForm', 'enctype' => 'multipart/form-data']) }}

Back

{{--

--}}

Retrospective Real-World Evidence (RWE) Study on the Efficacy of Teriparatide and Denosumab in the management of Osteoporosis

Patient No *

Patient Initials *

Baseline data collection

Date of completion of 1 year *

Patient's name initials *

Age (in Years) *

Gender *

Male Female

Name & address of Treating Orthopedic Surgeon *

All Inclusion & Exclusion criteria met *

Yes No

Medical/surgical history *

Physical examination *

Vital sign *

Information on treatment given- Investigational product, dosage, duration & route used *

Investigational Product used

Product	Dose	Month
Teriparatide
Denosumab
Combination of Teriparatide & Denosumab Dosage & Duration

Injection Compliance (%)*

Percentage change in Bone Mineral Density after 1 year *

At Lumbar

At Femoral Neck

Percentage change in Bone Markers*

Number of fractures in one year *

Concomitant medications Dosage*

Vitamin D3 Calcium

Adverse effects

Effect on Renal Function *

Affected Not Affected